The bill amends Section 21-28-3.18 of the Uniform Controlled Substances Act, specifically addressing the prescription and reporting of testosterone. It introduces new provisions stating that prescriptions for testosterone shall not be transmitted to or reported within the prescription drug monitoring database maintained by the Department of Health. Additionally, it mandates that the Department of Health and Human Services purge all existing records concerning the prescribing and dispensing of testosterone from the controlled substances prescriptions monitoring program. The act is set to take effect upon passage.

Statutes affected:
8318: 21-28-3.18